SMIM22 and breast carcinoma: The discovery of the CASIMO1 micropeptide by Polycarpou-Schwarz (Polycarpou-Schwarz et al., 2018) and colleagues in 2018 marked an important advancement in the study of breast cancer micropeptides, providing a new perspective for understanding the lipid metabolism regulation in hormone receptor-positive breast cancer.